News tagged with disease progression

Related topics: patients · chemotherapy · prostate cancer

Drug combo doesn't lengthen glioblastoma survival

(HealthDay)—In patients with progressive glioblastoma, treatment with lomustine plus bevacizumab does not confer a survival advantage over treatment with lomustine alone, according to a study published online Nov. 15 in ...

Nov 17, 2017
popularity0 comments 0

Subscribe to rss feed